$INBP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTEGRATED BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INTEGRATED BIOPHARMA INC. Get notifications about new insider transactions in INTEGRATED BIOPHARMA INC for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Option Exercise | A | 0.72 | 50,000 | 36,000 | 50,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | KAY E GERALD | Executive Chairman ... | Option Exercise | A | 0.72 | 100,000 | 72,000 | 100,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 0.65 | 50,000 | 32,500 | 50,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Option Exercise | A | 0.65 | 50,000 | 32,500 | 50,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | RIVA SHEPPARD | Co-Chief Executive ... | Option Exercise | A | 0.65 | 100,000 | 65,000 | 100,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | RIVA SHEPPARD | Co-Chief Executive ... | Option Exercise | A | 0.65 | 100,000 | 65,000 | 100,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Co-Chief Executive ... | Option Exercise | A | 0.65 | 100,000 | 65,000 | 100,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Director | Option Exercise | A | 0.65 | 50,000 | 32,500 | 50,000 | |
| Nov 20 2020 | INBP | INTEGRATED BIOPHAR ... | Masi Dina | Chief Financial Off ... | Option Exercise | A | 0.65 | 100,000 | 65,000 | 100,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Option Exercise | A | 0.23 | 150,000 | 34,950 | 150,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | KAY E GERALD | Executive Chairman ... | Option Exercise | A | 0.23 | 250,000 | 58,250 | 250,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | KAY E GERALD | Executive Chairman ... | Option Exercise | A | 0.23 | 250,000 | 58,250 | 250,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | RIVA SHEPPARD | Co-Chief Executive ... | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Co-Chief Executive ... | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
| May 29 2019 | INBP | INTEGRATED BIOPHAR ... | Masi Dina | Chief Financial Off ... | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
| Dec 19 2018 | INBP | INTEGRATED BIOPHAR ... | KAY E GERALD | Chief Executive Off ... | Grant | A | 0.10 | 100,000 | 10,000 | 5,262,556 | 5.2 M to 5.3 M (+1.94 %) |
| Dec 19 2018 | INBP | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Executive Vice Pres ... | Grant | A | 0.14 | 50,000 | 7,000 | 1,173,467 | 1.1 M to 1.2 M (+4.45 %) |
| Dec 19 2018 | INBP | INTEGRATED BIOPHAR ... | RIVA SHEPPARD | Executive Vice Pres ... | Grant | A | 0.14 | 50,000 | 7,000 | 1,173,467 | 1.1 M to 1.2 M (+4.45 %) |
| Aug 01 2018 | INBP | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.65 | 8,230,769 | 5,350,000 | 188,667 | -8,042,102 to 188.7 K (-102.35 %) |
| Aug 01 2018 | INBP | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.65 | 8,230,769 | 5,350,000 | 117,409 | -8,113,360 to 117.4 K (-101.45 %) |
| Aug 01 2018 | INBP | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.65 | 8,230,769 | 5,350,000 | 10,524,173 | 2.3 M to 10.5 M (+358.89 %) |
| Nov 22 2016 | INBP | INTEGRATED BIOPHAR ... | LAPLACA JOSEPH | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 50,000 | |
| Nov 22 2016 | INBP | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 50,000 | |
| Nov 22 2016 | INBP | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Option Exercise | A | 0.25 | 50,000 | 12,500 | 50,000 | |
| Nov 22 2016 | INBP | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 50,000 | |
| Jun 09 2015 | INB | INTEGRATED BIOPHAR ... | RIVA SHEPPARD | EXECUTIVE VICE PRES ... | Option Exercise | A | 0.09 | 250,000 | 22,500 | 250,000 | |
| Jun 05 2015 | INB | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 0.09 | 175,000 | 15,750 | 175,000 | |
| Jun 05 2015 | INB | INTEGRATED BIOPHAR ... | KAY CHRISTINA | EXECUTIVE VICE PRES ... | Option Exercise | A | 0.09 | 250,000 | 22,500 | 250,000 | |
| Jun 04 2015 | INB | INTEGRATED BIOPHAR ... | Masi Dina | CFO | Option Exercise | A | 0.09 | 250,000 | 22,500 | 250,000 | |
| Jun 04 2015 | INB | INTEGRATED BIOPHAR ... | KAY E GERALD | CEO AND PRESIDENT | Option Exercise | A | 0.10 | 300,000 | 30,000 | 300,000 | |
| Jun 03 2015 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Option Exercise | A | 0.09 | 50,000 | 4,500 | 50,000 | |
| Jun 03 2015 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Option Exercise | A | 0.10 | 50,000 | 5,000 | 50,000 | |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Option Exercise | P | 0.65 | 1 | 1 | 1 | |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Option Exercise | C | 2.00 | 3,133 | 6,266 | 3,133 | |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Option Exercise | P | 2.00 | 108 | 216 | 3,108 | |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,456,293 | 4.4 M to 4.5 M (+1.13 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,406,293 | 4.4 M to 4.4 M (+1.15 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,356,293 | 4.3 M to 4.4 M (+1.16 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,306,293 | 4.3 M to 4.3 M (+1.17 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,256,293 | 4.2 M to 4.3 M (+1.19 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,206,293 | 4.2 M to 4.2 M (+1.20 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,156,293 | 4.1 M to 4.2 M (+1.22 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,106,293 | 4.1 M to 4.1 M (+1.23 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,056,293 | 4 M to 4.1 M (+1.25 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 4,006,293 | 4 M to 4 M (+1.26 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,956,293 | 3.9 M to 4 M (+1.28 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,906,293 | 3.9 M to 3.9 M (+1.30 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,856,293 | 3.8 M to 3.9 M (+1.31 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,806,293 | 3.8 M to 3.8 M (+1.33 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,756,293 | 3.7 M to 3.8 M (+1.35 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 2,846,729 | 2.8 M to 2.8 M (+1.79 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | C | 0.00 | 1,356,293 | 0 | 2,990,934 | 1.6 M to 3 M (+82.97 %) |
| Jul 05 2012 | INB | INTEGRATED BIOPHAR ... | CD Financial, LLC | 10% Owner | Buy | J | 0.00 | 50,000 | 0 | 3,145,910 | 3.1 M to 3.1 M (+1.62 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Option Exercise | P | 0.65 | 1 | 1 | 1 | |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,582,960 | 4.5 M to 4.6 M (+1.10 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,532,960 | 4.5 M to 4.5 M (+1.12 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,482,960 | 4.4 M to 4.5 M (+1.13 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,432,960 | 4.4 M to 4.4 M (+1.14 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,382,960 | 4.3 M to 4.4 M (+1.15 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,332,960 | 4.3 M to 4.3 M (+1.17 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,282,960 | 4.2 M to 4.3 M (+1.18 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,232,960 | 4.2 M to 4.2 M (+1.20 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,182,960 | 4.1 M to 4.2 M (+1.21 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | Milmoe William H. | Director | Buy | J | 0.00 | 50,000 | 0 | 4,132,960 | 4.1 M to 4.1 M (+1.22 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Option Exercise | P | 0.65 | 1 | 1 | 1 | |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,771,011 | 6.7 M to 6.8 M (+0.74 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,721,011 | 6.7 M to 6.7 M (+0.75 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,671,011 | 6.6 M to 6.7 M (+0.76 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,621,011 | 6.6 M to 6.6 M (+0.76 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,571,011 | 6.5 M to 6.6 M (+0.77 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,521,011 | 6.5 M to 6.5 M (+0.77 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,471,011 | 6.4 M to 6.5 M (+0.78 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,421,011 | 6.4 M to 6.4 M (+0.78 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,371,011 | 6.3 M to 6.4 M (+0.79 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,321,011 | 6.3 M to 6.3 M (+0.80 %) |
| Jun 29 2012 | INB | INTEGRATED BIOPHAR ... | KAY E GERALD | CEO AND PRESIDENT | Sell | S | 0.09 | 250,000 | 22,500 | 5,270,444 | 5.5 M to 5.3 M (-4.53 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,303,355 | 6.3 M to 6.3 M (+0.80 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,253,355 | 6.2 M to 6.3 M (+0.81 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | P | 0.53 | 87,111 | 46,169 | 6,203,355 | 6.1 M to 6.2 M (+1.42 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,116,244 | 6.1 M to 6.1 M (+0.82 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,066,244 | 6 M to 6.1 M (+0.83 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | DESANTIS CARL | Director | Buy | J | 0.00 | 50,000 | 0 | 6,016,244 | 6 M to 6 M (+0.84 %) |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | RIVA KAY | Executive Vice Pres ... | Option Exercise | A | 0.14 | 90,000 | 12,600 | 90,000 | |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | KAY E GERALD | CEO and President | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 0.14 | 25,000 | 3,500 | 25,000 | |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Executive Vice Pres ... | Option Exercise | A | 0.14 | 90,000 | 12,600 | 90,000 | |
| Oct 28 2009 | INB | INTEGRATED BIOPHAR ... | Masi Dina | Chief Financial Off ... | Option Exercise | A | 0.14 | 150,000 | 21,000 | 150,000 | |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Vice President | Option Exercise | A | 6.80 | 16,000 | 108,800 | 616,666 | |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | KAY CHRISTINA | Vice President | Grant | A | 6.80 | 34,000 | 231,200 | 702,801 | 668.8 K to 702.8 K (+5.08 %) |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Option Exercise | A | 6.80 | 4,800 | 32,640 | 150,000 | |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | Canarick Robert | Director | Grant | A | 6.80 | 10,200 | 69,360 | 53,533 | 43.3 K to 53.5 K (+23.54 %) |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | RIVA KAY | Vice President | Option Exercise | A | 6.80 | 16,000 | 108,800 | 616,666 | |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | RIVA KAY | Vice President | Grant | A | 6.80 | 34,000 | 231,200 | 702,801 | 668.8 K to 702.8 K (+5.08 %) |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | Masi Dina | Chief Financial Off ... | Option Exercise | A | 6.80 | 12,800 | 87,040 | 50,000 | |
| Feb 15 2007 | INB | INTEGRATED BIOPHAR ... | Masi Dina | Chief Financial Off ... | Grant | A | 6.80 | 27,200 | 184,960 | 0 | -27,200 to 0 (-100.00 %) |
| Sep 18 2006 | INB | INTEGRATED BIOPHAR ... | Masi Dina | CFO and Sr. VP | Option Exercise | A | 3.13 | 18,052 | 56,503 | 18,052 | |
| Sep 18 2006 | INB | INTEGRATED BIOPHAR ... | Masi Dina | CFO and Sr. VP | Option Exercise | A | 3.13 | 31,948 | 99,997 | 31,948 | |
| Mar 24 2005 | INB | INTEGRATED BIOPHAR ... | KAY E GERALD | Chairman and CEO | Buy | P | 6.44 | 5,000 | 32,200 | 6,275,384 | 6.3 M to 6.3 M (+0.08 %) |
| Jan 14 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Option Exercise | X | 0.03 | 10,000 | 330 | 0 | |
| Jan 14 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Buy | X | 0.33 | 10,000 | 3,300 | 72,400 | 62.4 K to 72.4 K (+16.03 %) |
| Jan 14 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 6.93 | 600 | 4,155 | 62,400 | 63 K to 62.4 K (-0.95 %) |
| Jan 12 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 6.90 | 900 | 6,210 | 63,000 | 63.9 K to 63 K (-1.41 %) |
| Jan 12 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 6.90 | 1,000 | 6,900 | 63,900 | 64.9 K to 63.9 K (-1.54 %) |
| Jan 12 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 7.00 | 500 | 3,500 | 64,900 | 65.4 K to 64.9 K (-0.76 %) |
| Jan 11 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 6.85 | 3,000 | 20,550 | 68,500 | 71.5 K to 68.5 K (-4.20 %) |
| Jan 11 2005 | INB | INTEGRATED BIOPHAR ... | FRIEDMAN ERIC J | Chief Financial Off ... | Sell | S | 7.00 | 500 | 3,500 | 71,500 | 72 K to 71.5 K (-0.69 %) |
Page: 1